Johannes G. KHINAST

The digitalisation of Europe is advancing at enormous speed – and this is offering pharmaceutical companies the chance to communicate directly and frequently with individual patients for the first time. The development of intelligent medical products is helping to increase the quality of life and the life expectancy of patients, significantly and for the long term.